We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.31B
AUM Growth
+$72.1M
Cap. Flow
-$212M
Cap. Flow %
-6.41%
Top 10 Hldgs %
31.06%
Holding
111
New
31
Increased
21
Reduced
21
Closed
33

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$92.4M
2
BIIB icon
Biogen
BIIB
+$88.4M
3
BAX icon
Baxter International
BAX
+$59.5M
4
DISH
DISH Network Corp.
DISH
+$58.6M
5
META icon
Meta Platforms (Facebook)
META
+$53.6M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$110M
2
AAPL icon
Apple
AAPL
+$94.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$94M
4
LRCX icon
Lam Research
LRCX
+$90.7M
5
AGN
Allergan plc
AGN
+$84.2M

Sector Composition

Rank Sector Weight
1 Healthcare 38.8%
2 Technology 9.31%
3 Communication Services 4.67%
4 Energy 3.99%
5 Financials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMT icon
76
American Tower
AMT
$77.7B
– –
-123,422
Closed -$12.6M
BLK icon
77
Blackrock
BLK
$164B
– –
-189,158
Closed -$64.4M
CHTR icon
78
Charter Communications
CHTR
$14.7B
– –
-142,999
Closed -$28.9M
CRM icon
79
Salesforce
CRM
$134B
– –
-351,492
Closed -$26M
DVA icon
80
DaVita
DVA
$15.1B
– –
-173,585
Closed -$12.7M
DXCM icon
81
DexCom
DXCM
$27.6B
– –
-682,140
Closed -$11.6M
EEM icon
82
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
– –
-580,100
Closed -$19.9M
ELV icon
83
Elevance Health
ELV
$81.9B
– –
-518,909
Closed -$72.1M
GILD icon
84
Gilead Sciences
GILD
$161B
– –
-835,032
Closed -$76.7M
GOOGL icon
85
Alphabet (Google) Class A
GOOGL
$3.91T
– –
-2,042,300
Closed -$77.9M
HYG icon
86
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
– –
-287,300
Closed -$23.5M
IBB icon
87
iShares Biotechnology ETF
IBB
$9.31B
– –
-241,539
Closed -$21M
JD icon
88
JD.com
JD
$40.8B
– –
-230,412
Closed -$6.11M
HAPN
89
Happen Inc
HAPN
$2.08B
– –
-983,517
Closed -$40.8M
LRCX icon
90
Lam Research
LRCX
$382B
– –
-10,986,460
Closed -$90.7M
MKTX icon
91
MarketAxess Holdings
MKTX
$4.15B
– –
-105,161
Closed -$13.1M
NFLX icon
92
Netflix
NFLX
$292B
– –
-3,698,730
Closed -$37.8M
OEF icon
93
CALL
iShares S&P 100 ETF
OEF
$19.8B
– –
-424,700
Closed -$111M
PYPL icon
94
PayPal
PYPL
$49.5B
– –
-1,487,245
Closed -$57.4M
SAGE
95
DELISTED
Sage Therapeutics
SAGE
– –
-198,058
Closed -$6.35M
SYF icon
96
Synchrony
SYF
$23.7B
– –
-1,766,019
Closed -$50.6M
TCOM icon
97
Trip.com Group
TCOM
$27.5B
– –
-487,352
Closed -$21.6M
XBI icon
98
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-544,000
Closed -$28.1M
PXD
99
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-88,985
Closed -$12.5M
RAD
100
DELISTED
Rite Aid Corporation
RAD
– –
-94,408
Closed -$15.4M
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2016 Portfolio in Review

As of Q2 2016, PFM Health Sciences held 111 positions worth $3.31B, up 2.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $212M in Q2 2016, closing 33 positions and reducing 21 holdings. Its most notable exit was Lam Research, an estimated $90.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $81.1M.

  • PFM Health Sciences's largest Q2 2016 buy was Biogen: 335,290 shares worth $81.1M.
  • PFM Health Sciences added most to Aetna Inc in Q2 2016, an estimated $92.4M increase.
  • PFM Health Sciences's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $110M.
  • PFM Health Sciences fully exited Lam Research in Q2 2016, selling an estimated $90.7M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $3.31B portfolio in Q2 2016.
  • PFM Health Sciences opened 31 new positions and closed 33 in Q2 2016.
  • PFM Health Sciences's portfolio value rose 2.2% quarter-over-quarter to $3.31B.

Based on PFM Health Sciences's 13F filing for Q2 2016, filed 15 Aug 2016.